Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Press Releases

Press Releases

All Releases
View Summary NeoTherapeutics Provides Update on Nasdaq Listing Status
Sep 30, 2002
PDF 27.3 KB Add to Briefcase
View Summary NeoTherapeutics Regains Compliance with NASDAQ Minimum Bid Requirement
Sep 26, 2002
PDF 27.0 KB Add to Briefcase
View Summary NeoTherapeutics' Stockholders Approve Reverse Stock Split and Proposal for New Financings
Sep 5, 2002
PDF 29.2 KB Add to Briefcase
View Summary NeoTherapeutics Announces Organizational Changes Designed to Bring On-Going Monthly Expenses Below $500,000
Aug 22, 2002
PDF 30.1 KB Add to Briefcase
View Summary NeoTherapeutics Announces New Financial Leadership
Aug 21, 2002
PDF 27.9 KB Add to Briefcase
View Summary NeoTherapeutics Announces Major Strategic Restructuring
Aug 20, 2002
PDF 27.6 KB Add to Briefcase
View Summary NeoTherapeutics Names Dr. Rajesh Shrotriya Chairman and Chief Executive Officer
Aug 16, 2002
PDF 29.7 KB Add to Briefcase
Showing 701-707 of 707 Page: 1 ... 32 33 34 35 36  Previous 20
Add to Briefcase = add release to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
8.12
Change:
+ 0.08
Day High:
8.21
Day Low:
8.07
Volume:
696,977
4:00 PM ET on Jul 21, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR